Decreasing disease activity in people with rheumatoid arthritis (RA) has long been the goal of medical treatment. But measuring when a person has met their goal — when symptoms are alleviated or at a ...

Depression is associated with lower odds of achieving remission in patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) over 2 years of follow-up. Researchers analyzed data from two ...

Please provide your email address to receive an email when new articles are posted on . Approximately half of patients who reduced their disease-modifying antirheumatic drugs while in stable ...

Please provide your email address to receive an email when new articles are posted on . A higher threshold for patient global assessment — 2 cm rather than 1 cm — increases agreement between Boolean ...

WASHINGTON -- Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those with lingering low-level symptoms, a single-center study found -- casting ...

Rheumatoid arthritis (RA), a chronic, progressive, hard-to-diagnose, systemic autoimmune disease that manifests primarily in the synovial membrane of the joints but also in other organs, affects ...

If you or someone you love has rheumatoid arthritis, you’ve probably thought about remission from rheumatoid arthritis more than once. As you likely know, rheumatoid arthritis is a very serious ...

New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Nearly half of the patients with rheumatoid arthritis (RA) in sustained clinical and ultrasound remission still report unacceptable pain, with women experiencing higher pain levels than men. Patient ...

NORTH CHICAGO, Ill., Nov. 18, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the publication of results from a new literature review in Advances in Therapy. The literature review reported ...

New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi ...